Vaginal candidosis: Epidemiological and etiological factors

International Journal of Gynecology and Obstetrics

Volumn 71, Issue SUPPL. 1, 2000, Pages 21-27

  Ferrer, J ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Host factors; Microbiology; Pathogenesis; Vaginal candidosis

Indexed keywords

ANTIBIOTIC AGENT; ORAL CONTRACEPTIVE AGENT;

ANTIBIOTIC THERAPY; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL ADHESION; CELL INVASION; CELLULAR IMMUNITY; CONTRACEPTION; DIABETES MELLITUS; FUNGUS GROWTH; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; RISK FACTOR; VAGINA CANDIDIASIS; VAGINA FLORA; VIRULENCE;

EID: 0033670082     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0020-7292(00)00350-7     Document Type: Review

References (46)

1. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis
2. Candida vaginitis
3. Trends in candidal vaginitis
4. Recurrent candida infection
5. Candidal vulvovaginitis
6. Working group of the British Society for Medical Mycology. Management of genital candidiasis
7. Candida vulvovaginits
8. Chronic vulvovaginal candidiasis: Characteristics of women with Candida albicans, C. glabrata and no candida
9. Treatment of torulopsis glabrata vaginitis: Retrospective review of boric acid therapy
10. Vulvovaginitis due to Candida glabrata. An emerging problem
11. Torulopsis glabrata vaginitis: Clinical aspects and susceptibility to antifungal agents
12. Torulopsis glabrata vaginitis
13. Candidosis vulvo.vaginales recidivants. Manifestations cliniques, diagnostic mycologique, facteurs favorisants, traitement
14. Evolving pathogens in vulvovaginal candidasis: Implications for patient care
15. Frequency and significance of drug resistance in vulvovaginal candidiasis
16. Candida topicalis vulvovaginitis
17. Chronic fungal vaginitis: The value of cultures
18. Epidemiologic characteristics of women with idiopathic vulvovaginal candidiasis
19. Candida glabrata: Review of epidemiology pathogenesis and clinical disease with comparison to candida albicans
20. Adherence of Candida albicans and other candida species to mucosal epithelial cells
21. Acquisitions recentes sur la physiopathologie des candidosis vulvovaginales
22. Candida albicans adherence to vaginal epithelial cells
23. Estrogen receptor in Candida albicans. A possible explanation for hormonal influences in vaginal candidiasis
24. Immunopathogenesis of recurrent vulvovaginal candidiasis
25. Ketoconazole prophylaxis in experimental vaginal candidiasis
26. Experimental chronic vaginal candidiasis in rats
27. Scanning electron microscope study of Candida albicans invasion of cultured human cervical cells
28. Human genital candidosis. Histochemistry, scanning and transmission electron microscopy
29. The epidemiology of vulvovaginal candidiasis: Risk factors
30. The value of treating the sexual partner of women with recurrent vaginal candidiasis with ketoconazol
31. Microbial interference between indigenous yeast and lactobacilli in the rodent stomach
32. Les mycoses genitales chroniques. Physiopathologie, traitement: Jusqu'ou aller?
33. Beta-indole-ethanol and beta-indolel-acid production by Candida species: Their antibacterial and autoantibiotic action
34. Vaginal moniliasis after teracycline therapy
35. Effect of mynocicline and tetacycline on the vaginal yeast flora
36. IgA and IgI antibodies to Candida albicans in the genital tract secretions of women with and without vaginal candidiasis
37. Immunoglobulin E anti-Candida antibodies and candidiasis
38. Candidal vaginitis: Natural history, predisposing factors and prevention
39. Risk factors for vulvovaginal candidiasis. A case control study among university students
40. Predicting the occurrence of antibiotic induced candidal vaginitis
41. Risk factors for candida vulvovaginits